港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

麦科医药-B

28.240

-0.080-0.28%

成交量：18.00万

成交额：511.61万

市值：93.68亿

市盈率：- -

高：28.760

开：28.300

低：28.060

收：28.320

52周最高：45.040

52周最低：27.000

股本：3.32亿

香港流通股本：2.80亿

量比：0.96

换手率：0.06%

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：-33.17%

市净率：-8.26

市盈率(LYR):- -

市销率: 27423.78

数据加载中...

总览公司新闻资讯公告

麦科医药-B(02335)存仓市值总计5.21亿港元股东将1773.41万股股票存入Merrill Lynch Far East

麦科医药-B(02335)获纳入恒生综合指数成份股

麦科医药-B（02335）将于9月7日纳入恒生综合指数

陕西麦科医药科技（02335.HK）将于2026年9月7日纳入恒生综合指数

麦科医药－Ｂ(02335)股价上升5.145%，现价港币$31.88

阿斯达克财经

港股异动 | 麦科医药-B(02335)午后涨近6% 创新药XTL6001三登国际顶级学术舞台

麦科医药(02335.HK)XTL6001研究获接纳于公认学术会议作报告

阿斯达克财经

麦科医药-B（02335）主要产品XTL6001研究成果获EASD 2026及ASN Kidney Week 2026收录

麦科医药-B(02335.HK)：XTL6001的研究获接纳于EASD 2026及ASN KIDNEY WEEK 2026作报告

麦科医药-B(02335.HK)8月28日举行董事会会议批准中期业绩

麦科医药-B（02335）拟于8月28日召开董事会审议2026年中期业绩及派息方案

港股异动 | 麦科医药-B(02335)涨超3% MT200605临床前及I期临床数据获接纳于WSC 2026大会作口头报告

麦科医药(02335.HK)MT200605临床数据获接纳于WSC 2026作口头报告

阿斯达克财经

麦科医药-B(02335.HK)：MT200605的临床前及I期临床数据获接纳于2026年第十八届世界卒中大会作口头报告

麦科医药－Ｂ(02335)股价上升5.641%，现价港币$30.34

阿斯达克财经

麦科医药－Ｂ(02335)股价下跌5.574%，现价港币$28.8

阿斯达克财经

麦科医药脑梗创新药II期临床达主要终点，对标数十亿元市场

麦科医药-B 2026年7月无新增发行或股份变动

港股异动 | 麦科医药-B(02335)涨超3% MT200605治疗急性缺血性脑卒中的II期临床试验达到主要终点

麦科医药(02335.HK)候选药MT200605临床试验达主要终点

阿斯达克财经

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/02335/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02335","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02335\",,,,,undefined,":{"symbol":"02335","market":"HK","secType":"STK","nameCN":"麦科医药-B","latestPrice":28.24,"timestamp":1787630297116,"preClose":28.32,"halted":0,"volume":180000,"delay":0,"changeRate":-0.002824858757062212,"floatShares":280071100,"shares":331740350,"eps":0,"marketStatus":"午间休市","change":-0.08,"latestTime":"08-25 11:58:17","open":28.3,"high":28.76,"low":28.06,"amount":5116064,"amplitude":0.024718,"askPrice":28.24,"askSize":600,"bidPrice":28.1,"bidSize":600,"shortable":0,"etf":0,"ttmEps":-0.609,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787634000000},"marketStatusCode":3,"adr":0,"listingDate":1782230400000,"exchange":"SEHK","adjPreClose":28.32,"openAndCloseTimeList":[[1787621400000,1787630400000],[1787634000000,1787644800000]],"volumeRatio":0.959767,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02335\",,,,,undefined,":{"symbol":"02335","floatShares":280071100,"roa":"-33.17%","roe":"--","lyrEps":0,"volumeRatio":0.959767,"shares":331740350,"dividePrice":0,"high":28.76,"amplitude":0.024718,"preClose":28.32,"low":28.06,"week52Low":27,"pbRate":"-8.26","psRate":"27423.78","week52High":45.04,"institutionHeld":0,"latestPrice":28.24,"eps":0,"divideRate":0,"volume":180000,"delay":0,"ttmEps":-0.609,"open":28.3,"prevYearClose":18.2,"prevWeekClose":29.36,"prevMonthClose":28.72,"prevQuarterClose":36.54,"fiveDayClose":31.74,"twentyDayClose":28.14,"sixtyDayClose":18.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02335\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"02335","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02335\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02335\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02335\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02335","date":"2026-08-21","current":-46.502463,"percent":0.829268,"low":-69.768231,"twenty":-63.046152,"median":-53.612744,"eighty":-46.072055,"high":-30.846573,"avg":-53.69162,"sd":8.895528,"marketCap":9739896676},"quantilePoints":[{"date":"2026-06-26","current":-62.263046,"twenty":-62.206329,"median":-60.152258,"eighty":-47.220229,"marketCap":13110378632},{"date":"2026-07-03","current":-59.036408,"twenty":-61.58898,"median":-58.586203,"eighty":-56.979685,"marketCap":12440263125},{"date":"2026-07-10","current":-67.90436,"twenty":-64.475349,"median":-60.719674,"eighty":-57.773147,"marketCap":14291374278},{"date":"2026-07-17","current":-63.579874,"twenty":-66.545041,"median":-62.752488,"eighty":-58.496163,"marketCap":13428849368},{"date":"2026-07-24","current":-53.390071,"twenty":-65.175311,"median":-60.719674,"eighty":-54.684103,"marketCap":11279171900},{"date":"2026-07-31","current":-45.013396,"twenty":-64.653423,"median":-59.036408,"eighty":-53.47914,"marketCap":9527582852},{"date":"2026-08-07","current":-44.926163,"twenty":-63.868877,"median":-57.071612,"eighty":-46.373695,"marketCap":9527582852},{"date":"2026-08-14","current":-46.337925,"twenty":-63.512285,"median":-53.986784,"eighty":-46.072055,"marketCap":9839418781},{"date":"2026-08-21","current":-45.768087,"twenty":-63.046152,"median":-53.612744,"eighty":-46.072055,"marketCap":9739896676}],"updateTime":1787607308406},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02335\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662320734","title":"麦科医药-B(02335)存仓市值总计5.21亿港元 股东将1773.41万股股票存入Merrill Lynch Far East","url":"https://stock-news.laohu8.com/highlight/detail?id=2662320734","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662320734?lang=zh_cn&edition=fundamental","pubTime":"2026-08-25 09:07","pubTimestamp":1787620021,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，8月24日，麦科医药-B(02335)出现存仓异动，存仓市值总计5.21亿港元，占比6.33%。该公司股东将1773.41万股股票存入Merrill Lynch Far East。\r\n\r\n　　麦科医药发布公告，根据恒生指数有限公司于2026年8月21日公布的截至2026年6月30日止期间的恒生指数系列季度检讨结果，公司已获选并将纳入为恒生综合指数(恒生综指)成份股，自2026年9月7日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260825/32345698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661240441","title":"麦科医药-B(02335)获纳入恒生综合指数成份股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661240441","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661240441?lang=zh_cn&edition=fundamental","pubTime":"2026-08-24 12:11","pubTimestamp":1787544686,"startTime":"0","endTime":"0","summary":"智通财经APP讯，麦科医药-B(02335)发布公告，根据恒生指数有限公司于2026年8月21日公布的截至2026年6月30日止期间的恒生指数系列季度检讨结果，本公司已获选并将纳入为恒生综合指数(恒生综指)成份股，自2026年9月7日起生效。于获纳入恒生综指成份股后，本公司H股预期将符合资格获纳入沪港通及深港通。沪港通及深港通是香港与中国内地资本市场投资者进行股票交易及投资的渠道。董事会相信，获纳入恒生综指反映资本市场对本公司价值及成长潜力的认可，这将有助于拓宽本公司股东基础及提升其H股的交易流动性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484048.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02335","BK1161","HSCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105527001","title":"麦科医药-B（02335）将于9月7日纳入恒生综合指数","url":"https://stock-news.laohu8.com/highlight/detail?id=1105527001","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105527001?lang=zh_cn&edition=fundamental","pubTime":"2026-08-24 12:05","pubTimestamp":1787544330,"startTime":"0","endTime":"0","summary":"麦科医药-B（02335）8月24日公告称，根据恒生指数有限公司在2026年8月21日公布的截至2026年6月30日止期间恒生指数系列季度检讨结果，公司H股将被纳入恒生综合指数，生效日期为2026年9月7日。\n公司表示，纳入恒生综合指数后，其H股预计将符合资格被纳入沪港通及深港通，为香港与内地资本市场投资者提供交易渠道。\n董事会认为，此次纳指显示资本市场对公司价值及成长潜力的认可，并有助于拓宽股东基础及提升H股交易流动性。\n公司提醒股东及潜在投资者在买卖公司股份时保持审慎。公告由公司主席、首席执行官兼执行董事王冰于2026年8月24日签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140356227","title":"陕西麦科医药科技（02335.HK）将于2026年9月7日纳入恒生综合指数","url":"https://stock-news.laohu8.com/highlight/detail?id=1140356227","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140356227?lang=zh_cn&edition=fundamental","pubTime":"2026-08-24 12:05","pubTimestamp":1787544313,"startTime":"0","endTime":"0","summary":"陕西麦科医药科技股份有限公司传来重磅消息——该公司将被正式纳入恒生综合指数，这一变动自2026年9月7日起生效。此次将陕西麦科医药科技纳入其中，无疑是对该公司市值、流动性及行业代表性等多方面指标的肯定。总而言之，陕西麦科医药科技即将跻身恒生综合指数成分股行列，这不仅是对其过往经营成果的认可，更预示着其在资本市场新征程上的启航。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660450192","title":"麦科医药－Ｂ(02335)股价上升5.145%，现价港币$31.88","url":"https://stock-news.laohu8.com/highlight/detail?id=2660450192","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660450192?lang=zh_cn&edition=fundamental","pubTime":"2026-08-18 15:30","pubTimestamp":1787038200,"startTime":"0","endTime":"0","summary":"[上升股]麦科医药－Ｂ(02335) 股价在下午03:35比前收市价上升5.145%，现股价为港币$31.88。至目前为止，今日最高价为$31.88，而最低价为$31.88。总成交量为400股，总成交金额为港币$1.275万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608182336/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608182336/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660454482","title":"港股异动 | 麦科医药-B(02335)午后涨近6% 创新药XTL6001三登国际顶级学术舞台","url":"https://stock-news.laohu8.com/highlight/detail?id=2660454482","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660454482?lang=zh_cn&edition=fundamental","pubTime":"2026-08-18 13:48","pubTimestamp":1787032087,"startTime":"0","endTime":"0","summary":"消息面上，近日，麦科医药自主研发的创新药物XTL6001的肾脏病研究，成功入选2026年美国肾脏病学会肾脏周壁报展示。作为入选国家科技重大专项、斩获FDA孤儿药资质的小分子药物，MT200605凭借独有的全病程三重通路机制，直击国内脑梗治疗核心痛点，有望填补神经保护剂临床空白，重塑心脑血管创新药竞争格局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481245.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","02335","06978","BK1161","BK4585","BK4588","IBBQ","KCAI","BK1574","LNGR","159992","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660438423","title":"麦科医药(02335.HK)XTL6001研究获接纳于公认学术会议作报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2660438423","media":"阿斯达克财经","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660438423?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 21:22","pubTimestamp":1786972920,"startTime":"0","endTime":"0","summary":"麦科医药－Ｂ(02335.HK) 公布，集团其中一款主要产品XTL6001的研究成果，获接纳于糖尿病、代谢性疾病以及肾脏病领域的多场顶尖国际公认学术会议上作报告，包括第62届欧洲糖尿病研究协会年会“EASD 2026”，以及2026年美国肾脏病学会肾脏周“ASN Kidney Week 2026”。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260615090208913_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260615090208913_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1538785/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1538785/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107177771","title":"麦科医药-B（02335）主要产品XTL6001研究成果获EASD 2026及ASN Kidney Week 2026收录","url":"https://stock-news.laohu8.com/highlight/detail?id=1107177771","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107177771?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 18:45","pubTimestamp":1786963544,"startTime":"0","endTime":"0","summary":"麦科医药-B8月17日发布自愿性公告称，集团关键产品XTL6001的最新研究成果已获多项国际学术会议接纳并将作报告。EASD 2026将于2026年9月28日至10月2日在意大利米兰举行。此外，集团核心产品MT1013的相关研究成果曾获选于ASN Kidney Week 2025的Late-Breaking Research Posters环节展示。公司表示，XTL6001连续入选ADA、EASD及ASN等国际学术会议，标志着其在体重管理及肾脏病领域的研发进展迈出重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660481420","title":"麦科医药-B(02335.HK)：XTL6001的研究获接纳于EASD 2026及ASN KIDNEY WEEK 2026作报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2660481420","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660481420?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 18:40","pubTimestamp":1786963221,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659147209","title":"麦科医药-B(02335.HK)8月28日举行董事会会议批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2659147209","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659147209?lang=zh_cn&edition=fundamental","pubTime":"2026-08-14 22:27","pubTimestamp":1786717626,"startTime":"0","endTime":"0","summary":"格隆汇8月14日丨麦科医药-B(02335.HK)宣布，公司将于2026年8月28日(星期五)举行董事会会议，藉以(其中包括)批准公司及其附属公司截至2026年6月30日止六个月的未经审计中期业绩及其发布，考虑派发中期股息的建议(如有)，以及处理其他事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260814/32335962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124062847","title":"麦科医药-B（02335）拟于8月28日召开董事会 审议2026年中期业绩及派息方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1124062847","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124062847?lang=zh_cn&edition=fundamental","pubTime":"2026-08-14 21:45","pubTimestamp":1786715131,"startTime":"0","endTime":"0","summary":"陕西麦科奥特医药科技股份有限公司（02335）8月14日公告称，公司董事会将于2026年8月28日（星期五）召开会议，主要议程包括：一、审议并批准公司及其附属公司截至2026年6月30日止六个月的未经审计中期业绩及其发布；二、考虑派发中期股息的建议（如有）；三、处理其他事项。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658896964","title":"港股异动 | 麦科医药-B(02335)涨超3% MT200605临床前及I期临床数据获接纳于WSC 2026大会作口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2658896964","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658896964?lang=zh_cn&edition=fundamental","pubTime":"2026-08-11 11:39","pubTimestamp":1786419558,"startTime":"0","endTime":"0","summary":"消息面上，8月10日，麦科医药-B发布公告，本集团自主研发的用于治疗急性缺血性脑卒中的注射用神经保护候选药物MT200605的临床前及I期临床数据，已获接纳于2026年第十八届世界卒中大会作口头报告。在MT200605的临床前及I期临床数据获接纳于WSC 2026上作口头报告的同时，MT200605用于急性缺血性脑卒中的II期临床试验已获得具有统计学意义及临床相关性的结果，并达到主要终点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478376.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK1161","BK4588","02335","BK4129","KCAI","LU1878469433.USD","LU1815336091.USD","VXUS","LU0757428866.USD","WSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658493079","title":"麦科医药(02335.HK)MT200605临床数据获接纳于WSC 2026作口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2658493079","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658493079?lang=zh_cn&edition=fundamental","pubTime":"2026-08-11 00:03","pubTimestamp":1786377780,"startTime":"0","endTime":"0","summary":"麦科医药－Ｂ(02335.HK) 公布，集团自主研发用于治疗急性缺血性脑卒中(AIS)的注射用神经保护候选药物MT200605的临床前及I期临床数据，获接纳于2026年第十八届世界卒中大会“WSC 2026”作口头报告。WSC 2026将于10月21日至23日在韩国首尔举行。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260615090208913_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260615090208913_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1537491/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1537491/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658937540","title":"麦科医药-B(02335.HK)：MT200605的临床前及I期临床数据获接纳于2026年第十八届世界卒中大会作口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2658937540","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658937540?lang=zh_cn&edition=fundamental","pubTime":"2026-08-10 22:56","pubTimestamp":1786373772,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658600626","title":"麦科医药－Ｂ(02335)股价上升5.641%，现价港币$30.34","url":"https://stock-news.laohu8.com/highlight/detail?id=2658600626","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658600626?lang=zh_cn&edition=fundamental","pubTime":"2026-08-10 13:49","pubTimestamp":1786340940,"startTime":"0","endTime":"0","summary":"[上升股]麦科医药－Ｂ(02335) 股价在下午01:49比前收市价上升5.641%，现股价为港币$30.34。至目前为止，今日最高价为$30.34，而最低价为$28.38。总成交量为52.18万股，总成交金额为港币$1.511千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608101940/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608101940/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657936136","title":"麦科医药－Ｂ(02335)股价下跌5.574%，现价港币$28.8","url":"https://stock-news.laohu8.com/highlight/detail?id=2657936136","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657936136?lang=zh_cn&edition=fundamental","pubTime":"2026-08-07 11:00","pubTimestamp":1786071600,"startTime":"0","endTime":"0","summary":"[下跌股]麦科医药－Ｂ(02335) 股价在上午11:00比前收市价下跌5.574%，现股价为港币$28.8。至目前为止，今日最高价为$30.92，而最低价为$28.8。总成交量为24.8万股，总成交金额为港币$749.702万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD260807716/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD260807716/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158417515","title":"麦科医药脑梗创新药II期临床达主要终点，对标数十亿元市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1158417515","media":"21财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158417515?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 17:43","pubTimestamp":1785836628,"startTime":"0","endTime":"0","summary":"8月3日晚，麦科医药发布自愿性公告，宣布其自主研发的注射用神经保护候选药物MT200605在治疗急性缺血性脑卒中的II期临床试验中成功达到主要研究终点。截至目前，麦科已有7条管线进入临床，是国内进入临床试验阶段数量最多的多肽创新药企业。据麦科医药介绍，MT200605为自研创新药，通过静脉注射抵达脑组织内部。截至麦科医药上市，共有三种神经保护药物获国家药监局批准。根据公告，此次达到主要终点的II期临床试验共入组360名受试者。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"lsy1653463924952","url":"https://m.21jingji.com/article/20260804/herald/796fe5d0c1bcc58369f83b0c12f3a89f_zaker.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://m.21jingji.com/article/20260804/herald/796fe5d0c1bcc58369f83b0c12f3a89f_zaker.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1653463924952","symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153660594","title":"麦科医药-B 2026年7月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1153660594","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153660594?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 16:58","pubTimestamp":1785833884,"startTime":"0","endTime":"0","summary":"陝西麥科奧特醫藥科技股份有限公司于2026年8月4日发布2026年7月股份变动月报表，报告期为截至2026年7月31日。公司注册股本合计为6,634,807元人民币。报告期内，公司及其库藏股数量均未发生变动，H股及内资股发行量分别保持280,071,100股和51,669,250股不变，合计331,740,350股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656401580","title":"港股异动 | 麦科医药-B(02335)涨超3% MT200605治疗急性缺血性脑卒中的II期临床试验达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2656401580","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656401580?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 14:38","pubTimestamp":1785825519,"startTime":"0","endTime":"0","summary":"消息面上，8月3日，麦科医药-B发布公告，本集团自主研发的用于治疗AIS的候选药物MT200605的II期临床试验已获得顶线数据。数据显示，该临床试验已达到其主要研究终点，结果具有统计学显著性及临床意义。除用于治疗急性缺血性脑卒中外，MT200605亦正开发用于治疗亨廷顿舞蹈病。MT200605可选择性激活TrkB 信号通路，同时发挥神经保护及抗氧化双重作用，以保护神经组织的结构及功能。于2026年3月， MT200605针对HD适应症正式获得美国食品药品监督管理局孤儿药认定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475684.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","BMED","BK4588","02335","PSYK","BK1161","IBBJ","MDTX","IBBQ","BK4585","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656434370","title":"麦科医药(02335.HK)候选药MT200605临床试验达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2656434370","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656434370?lang=zh_cn&edition=fundamental","pubTime":"2026-08-03 23:10","pubTimestamp":1785769800,"startTime":"0","endTime":"0","summary":"麦科医药－Ｂ(02335.HK) 公布，集团自主研发用于治疗AIS的候选药物MT200605的II期临床试验已获得顶线数据。数据显示，该临床试验已达到其主要研究终点，结果具有统计学显著性及临床意义。整体上，MT200605在缺血性脑卒中患者中展现出显著、稳健的疗效，且安全性、耐受性良好。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260417085517124_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260417085517124_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1536348/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1536348/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":67,"code":"91000000","status":"200"}]}}